logo-loader
RNS
CVS Group

CVS Group plc - Transaction in Own Shares

RNS Number : 7853J
CVS Group plc
02 December 2025
 

02 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 01 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

01/12/2025

Aggregate number of Ordinary Shares purchased:

24,380

Lowest price paid per share (GBp):

1,216.00

Highest price paid per share (GBp):

1,230.00

Volume weighted average price paid per share (GBp):

1,221.26


CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,038,131 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 71,038,131 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 702,652 Ordinary Shares in aggregate at a weighted average price of 1,215.70 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 


460

1220

01/12/2025 08:18:20

1343423437085083

XLON


577

1218

01/12/2025 08:30:00

1343423437086574

XLON


257

1218

01/12/2025 09:02:05

1343423437089975

XLON


803

1220

01/12/2025 09:35:00

1343423437093273

XLON


288

1220

01/12/2025 09:36:11

1343423437093342

XLON


219

1220

01/12/2025 09:36:11

1343423437093343

XLON


331

1218

01/12/2025 09:43:40

1343423437093795

XLON


436

1218

01/12/2025 09:55:18

1343423437094684

XLON


112

1218

01/12/2025 09:56:01

1343423437094744

XLON


662

1222

01/12/2025 10:42:12

1343423437097500

XLON


94

1222

01/12/2025 10:42:12

1343423437097501

XLON


577

1220

01/12/2025 10:47:30

1343423437097853

XLON


120

1220

01/12/2025 10:47:33

1343423437097854

XLON


248

1220

01/12/2025 10:53:56

1343423437098182

XLON


294

1216

01/12/2025 10:54:06

1343423437098186

XLON


179

1216

01/12/2025 10:54:06

1343423437098187

XLON


735

1218

01/12/2025 11:05:05

1343423437098948

XLON


257

1218

01/12/2025 11:05:05

1343423437098950

XLON


478

1218

01/12/2025 11:05:05

1343423437098951

XLON


732

1218

01/12/2025 11:06:54

1343423437099051

XLON


732

1220

01/12/2025 11:13:09

1343423437099505

XLON


71

1218

01/12/2025 11:13:15

1343423437099509

XLON


71

1218

01/12/2025 11:13:21

1343423437099513

XLON


560

1220

01/12/2025 11:21:06

1343423437100114

XLON


771

1224

01/12/2025 12:05:48

1343423437103984

XLON


131

1222

01/12/2025 12:31:53

1343423437105501

XLON


80

1222

01/12/2025 12:31:53

1343423437105502

XLON


816

1220

01/12/2025 12:55:00

1343423437107024

XLON


826

1220

01/12/2025 12:55:00

1343423437107032

XLON


826

1218

01/12/2025 12:55:47

1343423437107085

XLON


71

1218

01/12/2025 13:01:19

1343423437107463

XLON


288

1224

01/12/2025 13:18:04

1343423437108804

XLON


200

1222

01/12/2025 13:45:07

1343423437111282

XLON


400

1222

01/12/2025 13:45:08

1343423437111283

XLON


41

1220

01/12/2025 13:50:26

1343423437111694

XLON


922

1220

01/12/2025 13:50:26

1343423437111695

XLON


200

1218

01/12/2025 13:50:32

1343423437111709

XLON


200

1218

01/12/2025 13:51:03

1343423437111754

XLON


971

1216

01/12/2025 13:52:00

1343423437111856

XLON


995

1216

01/12/2025 13:52:00

1343423437111857

XLON


559

1218

01/12/2025 13:52:58

1343423437111941

XLON


158

1218

01/12/2025 13:52:58

1343423437111942

XLON


1161

1220

01/12/2025 13:54:42

1343423437112080

XLON


653

1230

01/12/2025 15:34:26

1343423437128374

XLON


1

1230

01/12/2025 15:34:26

1343423437128375

XLON


64

1230

01/12/2025 15:34:31

1343423437128382

XLON


11

1230

01/12/2025 15:34:31

1343423437128383

XLON


1187

1228

01/12/2025 15:50:19

1343423437131054

XLON


84

1228

01/12/2025 15:50:21

1343423437131064

XLON


50

1228

01/12/2025 15:50:21

1343423437131065

XLON


7

1228

01/12/2025 15:50:21

1343423437131066

XLON


306

1228

01/12/2025 15:50:23

1343423437131070

XLON


330

1228

01/12/2025 15:59:41

1343423437132940

XLON


103

1228

01/12/2025 15:59:41

1343423437132945

XLON


111

1228

01/12/2025 15:59:41

1343423437132944

XLON


119

1228

01/12/2025 15:59:41

1343423437132943

XLON


158

1228

01/12/2025 15:59:41

1343423437132942

XLON


119

1228

01/12/2025 15:59:41

1343423437132941

XLON


8

1228

01/12/2025 16:01:24

1343423437133540

XLON


96

1228

01/12/2025 16:08:02

1343423437134985

XLON


191

1228

01/12/2025 16:08:02

1343423437134984

XLON


313

1228

01/12/2025 16:09:03

1343423437135203

XLON


199

1228

01/12/2025 16:09:03

1343423437135206

XLON


471

1228

01/12/2025 16:09:03

1343423437135204

XLON


24

1228

01/12/2025 16:09:03

1343423437135207

XLON


175

1228

01/12/2025 16:09:09

1343423437135224

XLON


270

1228

01/12/2025 16:15:03

1343423437136545

XLON


421

1228

01/12/2025 16:15:03

1343423437136546

XLON


 

 

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                             +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker)                                                                                                                         +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)                                                                                                                           cvsg@camarco.co.uk

Ginny Pulbrook                                                                                                                                            +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPGPCPUPAPWG
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Transaction in Own Shares

3 days, 16 hours ago

Transaction in Own Shares

1 week, 3 days ago

Transaction in Own Shares

2 weeks, 3 days ago

Total Voting Rights

2 weeks, 6 days ago

Transaction in Own Shares

3 weeks, 3 days ago

5 min read